Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Deschildre, J. Just, C. Marguet, J. L. Rittié, J. Derelle, I. Pin, R. Abou Taam, M. Fayon, J. Brouard, J. C. Dubus, D. Siret, L. Weiss, J. Salleron (Lille, Paris, Rouen, Toulouse, Nancy, Grenoble, Bordeaux, Caen, Marseille, Saint Nazaire, Strasbourg, France). Short term improvement of asthma control by omalizumab in difficult-to-treat asthmatic children: A French national survey. Eur Respir J 2010; 36: Suppl. 54, 2636

Member's Comments

No comment yet.

Related content which might interest you: Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey Source: Eur Respir J 2013; 42: 1224-1233 Year: 2013 Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018 Year: 2019 Childhood asthma control test in clinical management of Serbian asthmatic children Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Asthma control in Greek patients with asthma Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems Year: 2010 Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study Source: International Congress 2017 – Asthma management Year: 2017 Adherence to inhaled corticosteroids in asthmatic children in Dutch primary care Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012 The remarkable role of adherence to inhaled corticosteroids in achieving asthma control in young children with asthma Source: Annual Congress 2013 –Preschool wheeze Year: 2013 Effectiveness of montelukast on asthma control in infants: A claims data study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016 Short course montelukast for intermittent asthma in children: economic analysis of the PRE-EMPT study Source: Eur Respir J 2004; 24: Suppl. 48, 310s Year: 2004 The outcome of asthma among Greek children Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011 BTS Difficult Asthma Registry: Effect of omalizumab dosing table expansion on size of population of severe persistent allergic asthma patients potentially eligible for omalizumab therapy Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012 Paediatric asthma quality of life evaluation after Becotide® treatment of asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 145s Year: 2001 Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017 Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Asthma control is reached in a large majority of asthmatics treated with omalizumab. An Italian observational study Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013